
Established in 1964, Otsuka Pharmaceutical Co., Ltd. (OPC) conducts its business operations with the aim of contributing to better health for people worldwide under the Otsuka Group’s corporate philosophy of “Otsuka - people creating new products for better health worldwide.” Based on the two main businesses of pharmaceuticals that help treat illness—including the I.V. solutions business it has been engaged in since its founding—and Nutraceuticals Products that contribute to day-to-day wellness, OPC is engaged in the research and development, manufacture, and sale of innovative, creative products that make a difference in people’s health and well-being around the world.
| Name of Company | Otsuka Pharmaceutical Co., Ltd. |
|---|---|
| Head Office | 2-9 Kanda-Tsukasamachi, Chiyoda-ku Tokyo 101-8535, Japan |
| Tokyo Headquarters | Shinagawa Grand Central Tower 2-16-4 Konan, Minato-ku, Tokyo 108-0075 |
| Date Established | August 10, 1964 |
| President | Taro Iwamoto |
| Capital | 20 billion yen |
| Employees | 5,701 (as of March 31, 2012) |
| Business Description | Manufacturing, distributing, exporting, and importing of pharmaceuticals, clinical testing equipment, medical equipment, food products, cosmetics, and other related products |
| Business Premises | 17 branch offices, 51 district offices (in Japan) |
| Research Facilities | 18 divisions in 5 locations |
| Factories | 7 locations |
(as of June, 2011)